OverviewSuggest Edit

Emisphere Technologies is a commercial-stage pharmaceutical and drug delivery company. It develops the Eligen drug delivery technology that facilitates oral absorption of biologics products. The Company also provides Eligen B12, an oral medical food that normalizes B12 level.
HQRoseland, NJ, US

Latest Updates

Employees (est.) (Feb 2019)6(-50%)
Revenue (FY, 2016)$1.2 M(+191%)
Share Price (Dec 2020)$7.8
Cybersecurity ratingAMore

Key People/Management at Emisphere Technologies

M. Gary I. Riley

M. Gary I. Riley

Chief Scientific Officer
Phil Nikolayuk

Phil Nikolayuk

Director of Finance
David Gschneidner Ph

David Gschneidner Ph

Vice President, Carrier R&D
John D. Harkey

John D. Harkey

Louis Stamatellos

Louis Stamatellos

Director, Global Supply
Tim McInerney

Tim McInerney

Show more

Emisphere Technologies Office Locations

Emisphere Technologies has an office in Roseland
Roseland, NJ, US (HQ)
4 Becker Farm Rd
Show all (1)

Emisphere Technologies Financials and Metrics

Emisphere Technologies Revenue

Emisphere Technologies's revenue was reported to be $1.20 m in FY, 2016 which is a 190.8% increase from the previous period.

Revenue (Q1, 2017)


Gross profit (Q1, 2017)


Gross profit margin (Q1, 2017), %


Net income (Q1, 2017)


EBIT (Q1, 2017)


Market capitalization (11-Dec-2020)


Closing stock price (11-Dec-2020)


Cash (31-Mar-2017)

Emisphere Technologies's current market capitalization is $497.8 m.
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016



Revenue growth, %


Cost of goods sold


Gross profit

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017



Cost of goods sold


Gross profit


Gross profit Margin, %

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016



Accounts Receivable


Prepaid Expenses



USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Net Income


Depreciation and Amortization




Accounts Payable

Show all financial metrics

Emisphere Technologies Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Emisphere Technologies Online and Social Media Presence

Embed Graph

Emisphere Technologies News and Updates

Novo Nordisk Completes Acquisition of Emisphere Technologies for $1.35 Billion

ROSELAND, N.J., Dec. 08, 2020 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (“Emisphere” or the “Company”) today announced the completion of the previously announced transaction whereby Novo Nordisk A/S (“Novo Nordisk”) (NYSE: NVO) acquired Emisphere, on a cash-free, debt-free basis, for $1.35 …

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Emisphere Technologies, Inc. - EMIS

NEW YORK, Nov. 13, 2020 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating Emisphere Technologies, Inc. ("Emisphere" or the "Company") (EMIS)...

SHAREHOLDER ALERT: WeissLaw LLP Investigates Emisphere Technologies, Inc.

NEW YORK, Nov. 9, 2020 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Emisphere Technologies, Inc. ("EMIS" or the "Company") (OTC: EMIS) in connection with the proposed merger of the Company with...

Emisphere Technologies, Inc. (OTC:EMIS) INVESTOR NOTICE: Abraham, Fruchter & Twersky, LLP Is Investigating the Sale of Emisphere and Encourages Investors to Contact the Firm

NEW YORK, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Abraham, Fruchter & Twersky, LLP (www.aftlaw.com), a nationally recognized law firm that focuses on protecting investors’ rights, is investigating whether the board of directors of Emisphere Technologies, Inc. (“Emisphere” or the “Company”) (OTC:EMIS…

Kaskela Law LLC Announces Investigation of Emisphere Technologies, Inc. (EMIS) Following Acquisition Agreement

PHILADELPHIA, Nov. 9, 2020 /PRNewswire/ -- Kaskela Law LLC announces that it is investigating Emisphere Technologies, Inc. ("Emisphere") (OTC: EMIS) on behalf of the company's stockholders. On November 6, 2020, Emisphere announced that it had entered into an agreement to be acquired by...

David Polk Advises Novo Nordisk on Its Acquisition of Emisphere Technologies

Davis Polk is advising Novo Nordisk A/S on its $1.8 billion acquisition of Emisphere Technologies Inc.read more
Show more

Emisphere Technologies Frequently Asked Questions

  • When was Emisphere Technologies founded?

    Emisphere Technologies was founded in 1986.

  • Who are Emisphere Technologies key executives?

    Emisphere Technologies's key executives are M. Gary I. Riley, Phil Nikolayuk and David Gschneidner Ph.

  • How many employees does Emisphere Technologies have?

    Emisphere Technologies has 6 employees.

  • What is Emisphere Technologies revenue?

    Latest Emisphere Technologies annual revenue is $1.2 m.

  • What is Emisphere Technologies revenue per employee?

    Latest Emisphere Technologies revenue per employee is $199.2 k.

  • Who are Emisphere Technologies competitors?

    Competitors of Emisphere Technologies include Ampio Pharmaceuticals, Portola Pharmaceuticals and Otonomy.

  • Where is Emisphere Technologies headquarters?

    Emisphere Technologies headquarters is located at 4 Becker Farm Rd, Roseland.

  • Where are Emisphere Technologies offices?

    Emisphere Technologies has an office in Roseland.

  • How many offices does Emisphere Technologies have?

    Emisphere Technologies has 1 office.